Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two Medical Sciences Division scientists have been recognised in The Blavatnik Family Foundation and the New York Academy of Sciences Blavatnik Awards for Young Scientists, the largest unrestricted cash prizes available to scientists under the age of 42.

Eleanor Stride and Timothy Behrens

Professor Behrens and Professor Stride have been recognised in The Blavatnik Family Foundation and the New York Academy of Sciences Blavatnik Awards for Young Scientists, the largest unrestricted cash prizes available to scientists under the age of 42. 

Professor Timothy Behrens, from the Nuffield Department of Clinical Neuroscience (NDCN) at the University of Oxford receives a Laureateship worth £75,000 in the Life Sciences category. He has developed innovative models for mapping the brain's electrical signals that have significant implications for brain surgery, the treatment of mental disorders, and artificial intelligence.

Professor Eleanor Stride, from the Department of Engineering Science and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford, receives an award worth £23,000 as a Finalist. She is pioneering radical microbubble technology to develop more effective cancer treatments.

Read more about Timothy Behrens' research on the NDCN website

Read more about Eleanor Strides' research on the NDORMS website

Read the full story on University of Oxford website

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.